Juvenile Myasthenia Gravis. Our Experience with Good Therapeutic Effect of Thymectomy;Juvenilni myasthenia gravis. Naše zkušenosti s příznivým terapeutickým efektem tymektomie

Cesko-Slovenska Pediatrie

Volumn 53, Issue 11, 1998, Pages 670-678

  Kraus, J ^a   Pit'ha, J ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Children; Juvenile myasthenia gravis; Thymectomy

Indexed keywords

EID: 2442626837     PISSN: 00692328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Adams, C., Theodorescu, D., Murphy, G., Shanding, B.: Thymectomy in juvenile myasthema gravis. J. Child Neurol., 5, 1990, s. 216-218.
2. Afifi, A. K., Bell, W. E.: Tests for juvenile myasthenia gravis: Comparative diagnostic yield and prediction of outcome. J. Child Neurol., 8, 1993, s. 403-411.
3. Andrews, P. I., Massey, J. M., Howard, J. F. Jr., Sanders, D. B.: Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology, 44, 1994, s. 1208-1214
4. Argov, Z., Brener, T., Abramsky, O.: Ampicillin may aggravate clinical and experimental myasthenia gravis Arch. Neurol., 43, 1986, s. 255-256.
5. Blalock, A., Mason, M. F., Morgan, H. J., Riven, S. S.: Myasthenia gravis and tumors of the thymic region. Ann Surg., 110, 1939, s 544.
6. Bundey, S.: A genetic study of infantile and juvenile myasthenia gravis J. Neurol. Neurosurg. Psychiat., 35, 1972, s. 41-51.
7. Ciaccio, M., Parodi, A., Rebora, A.: Myasthenia gravis and lupus erythematosus. Int. J. Derm., 28, 1989, s. 317-320.
8. Compston, D. A. S., Vincent, A., Newson-Davis, J., Batchelor, J. R.: Clinical, pathological, HLA antigen, and immunological evidence for disease heterogeneity in myasthenia gravis. Brain, 103, 1980, s. 579-601.
9. Cornelio, F., Peluchetti, D., Mantegazza, R., Sghirlanzoni, A., Collarile, C.: The course of myasthenia gravis in patients treated with corticosteroids, azathioprine, and plasmapheresis. Ann. N Y. Acad Sci., 505, 1987, s. 517-525.
10. Čárský, S., Špalek, P., Schnorrer, M. Jr.: Myasthenia gravis a 93 thymektomíi. Strategia lieǒby a výsledky v rokoch 1990-1994 Rozhl. Chir., 74, 1995, s. 87-89.
11. Drachman, D. B.: Myasthenia gravis. New Engl. J. Med., 330, 1994, s. 1797-1810.
12. Fonkalsrud, E. W., Herrmann, C. Jr., Mulder, D. G.: Thymecromy for myasthenia gravis on children. J Pediatr Surg., 5, 1970, s 157-165.
13. Fukuyama, Y., Hirayama, Y., Osawa, M.: Epidemiological and clinical features of childhood myasthenia gravis in Japan. Japan Medical Research Foundation (ed.): Myasthenia Gravis. Tokyo, University Tokyo Press 1981, s. 19-28.
14. Genkins, G., Papatestas, A. E., Horowitz, S. H., Kornfeld, P.: Studies of myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations. Amer. J. Med., 58, 1975, s. 517-524
15. Hatton, P. D., Diehl, J. T., Daly, B. D. et al.: Transsternal radical thymectomy for myasthenia gravis: a 15-year review Ann Thorac. Surg, 47, 1989, s. 838-840.
16. Christensen, P. B., Jensen, T. S., Tsiropoulos, I. et al.: Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989 Neurology, 43, 1993, s. 1779-1783.
17. Jaretzki, A. III., Penn, A. S., Younger, D. S. et al: "Maximal" thymectomy for myasthenia gravis J. Thorac Cardiovasc. Surg., 95, 1988, s. 747-757.
18. Johns, T. R.: Long-term corticosteroid treatment of myasthenia gravis Ann N Y. Acad. Sci, 505, 1987, s. 568-583.
19. Jolly, R.: Über Myasthenia gravis pseudoparalytica. Berlin, klin. Wschr , 32, 1895, s 1.
20. Keller, O.: Patogeneze a klasifikace poruch nervosvalového přenosu Čes a Slov Neurol. Neurochir., 60/93, 1997, s. 3-11.
21. Keynes, G.: Surgery of the thymus gland Lancet, i, 1954, s. 1197.
22. Kraus, J., Vejvalka, J.: The follow up of children with juvenile myasthenia gravis treated by thymectomy. Abstract The Joint Convention of the 5th ICNA Congress and the 3rd Asian and Oceanian Congress of Child Neurology. 4. -9. 11. 1990, Tokyo, 645 s.
23. Lindner, A., Schalke, B., Toyka, K. V.: Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients. J. Neurol., 244, 1997, s. 515-520.
24. Lindstrom, J. M., Seybold, M. E., Lennon, V. A., Whittingham, S., Duane, D. D.: Antibody to acetylcholine receptor in myasthenia gravis prevalence, clinical correlates, and diagnostic value. Neurology, 26, 1976m s 1054-1059.
25. Magni, G., Micaglio, G., Ceccato, M. B., Lalli, R., Bejato, L., Angelini, C.: The role of life events in the myasthenia gravis outcome: a one-year longitudinal study. Acta Neurol. Scand., 79, 1989, s. 288-291.
26. Mattel, G.: Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis. Ann. N. Y. Acad. Sci., 505, 1987, s. 588-594.
27. May, E. F., Calvert, P. C.: Aggravation of myasthenia gravis by erythromycin Ann. Neurol, 28, 1990, s. 577-579.
28. Maytal, J., Spiro, A. J., Shinnar, Sh., Moshe, S. L.: The coexistence of myasthenia gravis and myotonic dystrophy in one family. Neuropediatrics, 18, 1987, s. 8-10.
29. Millichap, J. G., Dodge, P. R.: Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescence. Neurology, 10, 1960, s. 1007-1014.
30. Newsom-Davis, J.: Diseases of the neuromuscular junction In: Asbury, A. K., McKhann, G. M., McDonald, W. I. (eds.): Diseases of the Nervous System. London, Heinemann 1992, s. 197-212
31. Oosterhuis, H., Limburg, P. C., Hummel-Tappel, E.: Anti-acetylcholine receptor antibody in myasthenia gravis: II. Clinical and serological follow-up of individual patients. J. Neurol. Sci., 58, 1983, s 371-385
32. Osawa, M., Hirasawa, K., Fukuyama, Y.: Myasthenia gravis in childhood In: Fukuyama, Y., Kamoshita, S., Ohtsuka, C. et al. (eds.): Modern Perspectives of Child Neurology. Proceedings II of the Joint Convention of the 5th ICNA Congress and the 3rd Asian and Oceanian Congress of Child Neurology. Tokyo, 4 - 9 November 1990. Tokyo, Japanese Society of Child Neurology.
33. Osawa, M., Hirayama, Y., Suzuki, H. et al.: Myasthenia gravis in childhood. 3rd International Congress of Child Neurology, Denmark, Copenhagen, 28. 5. 1982.
34. Osserman, K. E.: Progress report on Mestinon bromide (Pyndostigmine bromide). Amer. J Med., 19, 1955, s 737.
35. Osserman, K. E.: Myasthenia Gravis. New York, Grune and Straton 1958.
36. Perlo, V. P., Poskanzer, D. C., Schwab, R. S., Viets, H. R., Osserman, K. E., Genkins, G.: Myasthenia gravis, evaluation of treatment in 1,355 patients. Neurology, 16, 1966, s. 431-439.
37. Pitha, J.: Současné léčebné moz̄nosti myasthenia gravis. Remedia, 4, 1994. s 166-173.
38. Pitha, J., Bakosová, M., Šmat, V., Tichy, J., Šimková L.: Praktické zkušenosti s diagn ostikou a terapií myasthenia gravis. Prakt. Lék., 9, 1995, s. 415-420.
39. Pitha, J., Matějková, E.: Asociace HLA antigenů. s myasthenia gravis u české populace. Čes. a Slov. Neurol. Neurochir, 61/94, 1998, s 7-12.
40. Rider, L. G., Sherry, D. D., Glass, S. T.: Neonatal lupus erytematosus simulating transient myasthenia gravis at presentation. J Pediatr, 118, 1991, s. 417-419.
41. Rodriguez, M., Gomez, M. R., Howard, F. M., Taylor, W. F.: Myasthenia gravis in children: Long term follow-up. Ann. Neurol., 13, 1983, s. 504-510.
42. Rowland, L. P.: Controversies about the treatment of myasthenia gravis J Neurol. Neurosurg. Psychiatr., 43, 1980, s. 644-659.
43. Ryniewicz, B.: Miastenia dziecieca - obraz kliniczny i wyniki leczenia. Neurol. Neurochir. Psychiatr. Polska, 25, 1975, č. 9, s. 481.
44. Ryniewitz, B., Badurska, B.: Follow-up study of myasthenic children after thymectomy. J. Neurol., 217, 1977, s. 133-138.
45. Sarnat, H. B., McGarry, J. D., Lewis, J. E. Jr.: Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy. Neurology, 27, 1977, s. 550-553.
46. Seybold, M. E., Howard, F. M., Duane, D. D. et al.: Thymectomy in juvenile myasthenia gravis. Arch Neurol., 25, 1971, s. 385-392.
47. Schalke, B, Kappos, L., Dommasch, D., Rohrbach, E., Mertnes, H. G.: Cyclosporin-A treatment of myasthenia gravis: initial results of a double blind trial of cyclosporin-A versus azathioprine Ann. N. Y. Acad. Sci., 505, 1987, s. 872-875.
48. Simpson, J. A.: An evaluation of thymectomy in myasthenia gravis. Brain, 81, 1958, s. 112.
49. Somnier, F. E., Keiding, N., Paulson, O. B.: Epidemiology of myasthenia gravis in Denmark: a longitudinal and comprehensive population survey. Arch Neurol., 48, 1991, s. 733-739.
50. Špalek, P.: Kongenitální myasthenické syndromy. Čs Neurol. Neurochir., 54/87, 1991, s. 198-200.
51. Tindall, R. S. A., Philips, J. T., Rollins, J. A., Wells, L., Hall, K.: A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann. N. Y. Acad. Sci., 681, 1993, s. 539-551.
52. Tzartos, S., Langeberg, L., Hochschwender, S., Swanson, L., Lindstrom, J.: Charakterization of monoclonal antibodies to denaturated Torpedo and to native calf acetylcholine receptors: spedies, subunit and region specificity. J. Neuroimmunol, 10, 1986, s. 235-253.
53. Vincent, A., Newson-Davis, J.: Acetylcholine receptor antibodies as a diagnostic test for myasthenia gravis results in 153 validated cases and 2967 diagnostic assays J Neurol Neurosurg. Psychiatr., 48, 1985, s. 1246-1252
54. Whyte, R. I., Kaplan, D. K., Deegan, S. P., Donnelly, R. J.: Cervical thymectomy in the treatment of myasthenia gravis. J. Roy Coll. Surg. (Edinb ), 34, 1989, s. 74-78.
55. Wilfong, A. A., Fernandez, F.: Myasthenia gravis in a child with sequelae of opsoclonus-myoclonus syndrome Canad. J. Neurol. Sci., 19, 1992, s. 88-89.
56. Wong, V., Hawkins, B. R., Yu, Y. L.: Myasthenia gravis in Hong Kong Chinese, 2. Pediatric disease. Acta Neurol. Scand., 86, 1992, s. 68-72.